A muscle-relaxant drug used to relieve muscle spasm caused by spinal injury, stroke, or neurological disorders such as cerebral palsy. The drug does not cure the underlying disorder, but often improves mobility.
A muscle-relaxing drug, indicated for chronic severe spasticity (see SPASTIC) of voluntary muscle such as may occur after a STROKE or in CEREBRAL PALSY and MULTIPLE SCLEROSIS (MS). Unlike most other relaxants, it acts directly on the muscle, thus producing fewer centralnervous-system side-effects. It is contraindicated if liver function is impaired, and is not recommended for children or for acute muscle spasm. It may cause drowsiness, resulting in impaired performance at skilled tasks and driving.
n. a *muscle relaxant drug used to relieve spasticity in such conditions as cerebral palsy, multiple sclerosis, and spinal cord injury. Possible side-effects include weakness, dizziness, drowsiness, and diarrhoea; liver damage sometimes occurs. It is also used to treat malignant hyperthermia, a serious complication of anaesthesia.
This disorder is a rare complication of general ANAESTHESIA caused, it is believed, by a combination of an inhalation anaesthetic (usually HALOTHANE) and a muscle-relaxant drug (usually succinycholine). A life-endangering rise in temperature occurs, with muscular rigidity the ?rst sign. TACHYCARDIA, ACIDOSIS and SHOCK usually ensue. About 1:20,000 patients having general anaesthesia suffer from this disorder, which progresses rapidly and is often fatal. Surgery and anaesthesia must be stopped immediately and appropriate corrective measures taken, including the intravenous administration of DANTROLENE. It is a dominantly inherited genetic condition; therefore, when a case is identi?ed it is most important that relatives are screened.... malignant hyperthermia
These drugs produce partial or complete paralysis of skeletal muscle (see under MUSCLE – Structure of muscle). Drugs in clinical use are all reversible and are used to help insert a breathing tube into the TRACHEA (endotracheal tube) during general ANAESTHESIA and ARTIFICIAL VENTILATION OF THE LUNGS. They may be broadly divided into depolarising and nondepolarising muscle relaxants. Depolarising muscle relaxants act by binding to acetylcholine receptors at the motor end-plate where nerves are attached to muscle cells, and producing a more prolonged depolarisation than acetylcholine, which results in initial muscle fasciculation (overactivity) and then ?accid paralysis of the muscle. The only commonly used depolarising drug is succinylcholine which has a rapid onset of action and lasts approximately three minutes. Non-depolarising muscle relaxants bind to the acetylcholine receptors, preventing acetylcholine from gaining access to them. They have a slower onset time and longer duration than depolarisers, although this varies widely between di?erent drugs. They are competitive antagonists and they may be reversed by increasing the concentration of acetylcholine at the motor end-plate using an anticholinesterase agent such as neostigmine. These drugs are broken down in the liver and excreted through the kidney, and their action will be prolonged in liver and renal failure. Other uses include the relief of skeletal muscle spasms in TETANUS, PARKINSONISM and spastic disorders. The drugs dantrolene and diazepam are used in these circumstances.... muscle relaxants
an agent that reduces tension in voluntary muscles. Drugs such as *baclofen, *dantrolene, and *diazepam are used to relieve skeletal muscular spasms in various spastic conditions, parkinsonism, and tetanus. The drugs used to relax voluntary muscles during the administration of anaesthetics in surgical operations act by blocking the transmission of impulses at neuromuscular junctions. Nondepolarizing muscle relaxants, e.g. *atracurium besilate, cisatracurium, pancuronium, and rocuronium, bind to receptor sites normally occupied by acetylcholine; depolarizing muscle relaxants, e.g. *suxamethonium, mimic the action of acetylcholine but *depolarization is prolonged.... muscle relaxant